Compare CDMOs with pharmaceutical packaging and labeling capabilities including blister packaging, bottling, serialization, and clinical trial labeling.
494 companies listed
Packaging and labeling is the final manufacturing step before distribution. Primary packaging (blisters, bottles, vials, pouches) directly contacts or contains the product. Secondary packaging (cartons, inserts, cases) provides information and protection. Both must comply with regulatory requirements for labeling content, child resistance, and serialization/track-and-trace.
Serialization is now mandatory in most major markets. The Drug Supply Chain Security Act (DSCSA) in the US, EU Falsified Medicines Directive (FMD), and similar regulations globally require unique serial numbers on each unit, enabling track-and-trace through the distribution chain. CDMOs must have validated serialization lines integrated with their packaging operations.
India
Senores Group (Senores Pharmaceuticals Limited) is an India-based CDMO specializing in complex generic oral solid dosage forms and API manufacturing. The company operates 5 manufacturing facilities including 2 USFDA-approved formulation plants (Atlanta, USA and Gujarat, India) and 2 API/intermediates plants. Senores serves 300+ customers in 49 countries, with particular strength in controlled substances (C2-C5), extended-release, and orally disintegrating tablet formulations.
India
Sentiss Pharma Pvt. Ltd. is an India-based pharmaceutical company specializing in ophthalmic, inhalation (nebulization), otic, and nasal drops, with contract manufacturing capabilities. The company operates sterile manufacturing lines including BFS (Blow-Fill-Seal) technology for eye drops and sterile liquid filling. Sentiss has FDA-registered facilities and has been the first Indian company to introduce eye drops in the Russian market using BFS technology.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.